Ron Zeheb

892 total citations
17 papers, 775 citations indexed

About

Ron Zeheb is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ron Zeheb has authored 17 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Ron Zeheb's work include Protease and Inhibitor Mechanisms (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Biotin and Related Studies (3 papers). Ron Zeheb is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Biotin and Related Studies (3 papers). Ron Zeheb collaborates with scholars based in United States, Denmark and Brazil. Ron Zeheb's co-authors include Thomas Gelehrter, John A. Libertino, Massimo Loda, Brasil Silva Neto, Kimberly Rieger‐Christ, Ian C. Summerhayes, Jens Eriksen, John Rømer, Peter Kristensen and Elisabeth Ralfkiær and has published in prestigious journals such as Analytical Biochemistry, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Ron Zeheb

17 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron Zeheb United States 13 384 323 190 171 127 17 775
Signe Ingvarsen Denmark 16 329 0.9× 351 1.1× 283 1.5× 82 0.5× 77 0.6× 21 817
Grainne A. McMahon United States 12 578 1.5× 439 1.4× 134 0.7× 234 1.4× 63 0.5× 13 1.0k
Rosemarie Chirco United States 4 310 0.8× 320 1.0× 237 1.2× 90 0.5× 52 0.4× 4 662
Christine Grignet‐Debrus Belgium 7 392 1.0× 308 1.0× 138 0.7× 114 0.7× 34 0.3× 9 647
Xavier Canron France 11 614 1.6× 136 0.4× 285 1.5× 66 0.4× 100 0.8× 12 879
Fumihiko Matsuno Japan 15 590 1.5× 226 0.7× 345 1.8× 134 0.8× 62 0.5× 31 986
Shinobu Iwai Japan 3 745 1.9× 356 1.1× 504 2.7× 53 0.3× 78 0.6× 6 1.3k
John M. Garland United Kingdom 9 528 1.4× 144 0.4× 171 0.9× 71 0.4× 92 0.7× 18 878
Frank Reiher Germany 12 628 1.6× 266 0.8× 140 0.7× 40 0.2× 182 1.4× 19 967
Hyeong-Reh Choi Kim United States 11 694 1.8× 344 1.1× 481 2.5× 84 0.5× 76 0.6× 11 1.3k

Countries citing papers authored by Ron Zeheb

Since Specialization
Citations

This map shows the geographic impact of Ron Zeheb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Zeheb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Zeheb more than expected).

Fields of papers citing papers by Ron Zeheb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Zeheb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Zeheb. The network helps show where Ron Zeheb may publish in the future.

Co-authorship network of co-authors of Ron Zeheb

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Zeheb. A scholar is included among the top collaborators of Ron Zeheb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Zeheb. Ron Zeheb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kenney, Patrick A., Matthew Wszolek, Kimberly Rieger‐Christ, et al.. (2010). Novel ZEB1 expression in bladder tumorigenesis. British Journal of Urology. 107(4). 656–663. 49 indexed citations
2.
Bogen, Steven A., et al.. (2009). Experimental Validation of Peptide Immunohistochemistry Controls. Applied immunohistochemistry & molecular morphology. 17(3). 239–246. 13 indexed citations
3.
Mandeville, Jessica A., Brasil Silva Neto, Alex J. Vanni, et al.. (2008). P‐cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells. British Journal of Urology. 102(11). 1707–1714. 33 indexed citations
4.
Manchio, Jeffrey V., et al.. (2008). Evaluation of a Novel Reverse Thermosensitive Polymer for Use in Microvascular Surgery. Journal of Reconstructive Microsurgery. 25(1). 69–76. 9 indexed citations
5.
Neto, Brasil Silva, Jessica A. Mandeville, Alex J. Vanni, et al.. (2007). Prognostic significance of altered p120 ctn expression in bladder cancer. British Journal of Urology. 101(6). 746–752. 11 indexed citations
6.
Cohen, Michael S., Brasil Silva Neto, Micah A. Jacobs, et al.. (2007). Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors. Clinical Cancer Research. 13(6). 1685–1694. 156 indexed citations
7.
Rømer, John, Leif R. Lund, Jens Eriksen, et al.. (1991). Differential Expression of Urokinase-Type Plasminogen Activator and Its Type-1 Inhibitor During Healing of Mouse Skin Wounds. Journal of Investigative Dermatology. 97(5). 803–811. 136 indexed citations
8.
Allan, Elizabeth, Ron Zeheb, Thomas Gelehrter, et al.. (1991). Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase‐type PA, PA inhibitor‐1 mRNA, and protein in rat osteoblast‐like cells. Journal of Cellular Physiology. 149(1). 34–43. 52 indexed citations
9.
Zeheb, Ron, et al.. (1991). Schwann cell plasminogen activator is regulated by neurons. Glia. 4(5). 514–528. 24 indexed citations
10.
Higgins, Paul J., et al.. (1990). p52 induction by cytochalasin D in rat kidney fibroblasts: Homologies between p52 and plasminogen activator inhibitor type‐1. Journal of Cellular Physiology. 143(2). 321–329. 33 indexed citations
11.
Zeheb, Ron & Thomas Gelehrter. (1988). Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene. 73(2). 459–468. 123 indexed citations
13.
Zeheb, Ron, et al.. (1987). Use of antibodies to probe membrane glycoproteins associated with drug-resistant J774.2 cells. Biochemical and Biophysical Research Communications. 143(2). 732–739. 29 indexed citations
14.
Zeheb, Ron, et al.. (1987). Immunoaffinity Purification of HTC Rat Hepatoma Cell Plasminogen Activator-Inhibitor-1. Thrombosis and Haemostasis. 58(4). 1017–1023. 34 indexed citations
15.
Zeheb, Ron & George A. Orr. (1986). [15] Use of avidin-iminobiotin complexes for purifying plasma membrane proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 122. 87–94. 10 indexed citations
16.
Orr, George A., et al.. (1986). [14] Purification of avidin and its derivatives on 2-iminobiotin-6-aminohexyl-sepharose 4B. Methods in enzymology on CD-ROM/Methods in enzymology. 122. 83–87. 9 indexed citations
17.
Zeheb, Ron, Vivian Y. Chang, & George A. Orr. (1983). An analytical method for the selective retrieval of iminobiotin-derivatized plasma membrane proteins. Analytical Biochemistry. 129(1). 156–161. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026